Portfolio company
HandyLab
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
HandyLab manufactures molecular diagnostic systems for clinical laboratories to automate the detection of infectious diseases.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
DxLab
This company develops point-of-care molecular testing systems and rapid diagnostic tests for pathogens to serve healthcare providers and public health teams.
NeuMoDx Molecular
The company develops automated molecular diagnostic systems and reagents for nucleic acid testing in clinical and hospital laboratories.
Abacus Diagnostica
This company develops molecular diagnostic systems for infectious disease testing, serving hospital laboratories and healthcare units.
iFAST Diagnositcs
The company develops rapid antimicrobial susceptibility testing systems for hospitals and clinical laboratories to identify effective antibiotic treatments for bacterial infections.
Pattern Diagnostics
This company develops single-cell microbiology systems for rapid pathogen identification and antibiotic susceptibility testing, serving hospital and clinical microbiology laboratories.
StatDx
This company develops point-of-care molecular diagnostic systems for healthcare providers to identify infectious diseases and critical care conditions.
Anvil Diagnostics
This company develops molecular blood tests to identify and quantify pathogens in hospitalised patients using digital PCR hardware.
Pattern Biosciences
This company develops single-cell microbiology diagnostic systems for rapid bacterial identification and antibiotic susceptibility testing for clinical laboratories and hospital settings.
